PAD
33
5
5
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.1%
3 terminated out of 33 trials
81.3%
-5.3% vs benchmark
0%
0 trials in Phase 3/4
54%
7 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (33)
The THOR IDE Study
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability
Distrupt Stiffness Trial
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
IVUS-Guided Treatment for Percutaneous Vascular Interventions
MSOT_PI Analysis of Revascularization Procedure Using Optoacoustic Imaging
Effect of Breather in COPD Patients with Intermittent Claudication
Tack Optimized Balloon Angioplasty Post-Market Study
Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
Treatment of No-option CLI by G-CSF-mobilized PB-MNC
Micro-mobile Foot Compression and Diabetic Foot
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair